Neumitra

Neumitra develops embedded biomodules to accurately and continuously measure how the autonomic nervous system is affected by daily stresses, to establish the relationship between brain health and performance. The company uses mobile software to link contextual data such as events, locations, and activities, with the physiology of stress, sleep, and exercise. Their internet-based analytics platform is designed to preserve participant anonymity while uncovering health risk factors worldwide.

Research has long linked excessive stress to a host of physical and mental health concerns, from heart disease, asthma, and fertility to anxiety disorders and depression. Neumitra’s mission is to quantify brain health with a validated stress score for real-time managing of symptoms, identifying their causes, and aiding users and their doctors in managing follow-on health concerns. Neumitra’s biomodules, already available as the neuma biowatch, measure signals associated with the autonomic nervous system including heart rate, skin conductance, temperature, and physical activity to develop a library of personal and population algorithms. The company is currently licensing its biomodules to watch and jewellery manufacturers for widespread applications.

Sector

Digital Health – Wearables

Management Team

Rob Goldberg, CEO

Company HQ

Boston, MA, USA

Website

www.neumitra.com